StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) bonds

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

AnaptysBio reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in AnaptysBio's 10-K for the period ended Jan 31, 2016

IssueCouponAmount issued
Term A Loans6.97%–
Term B and Term C Loans–$10.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?